State Funding Information Archive 2009-2016

On This Page

AL  AK  AZ  AR  CA  CO  CT  DE  DC  FL  GA  HI  ID IL  IN IA  KS  KY  LA ME  MD MA  MI  MN  MS  MO  MT NE  NV NH  NJ  NM  NY NC  ND  OH  OK OR  PA  PR  RI  SC  SD  TN  TX  UT  VT  VA  WA  WV  WI  WY

Alabama

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $397,540
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $213,362
    • Targeted Infection Prevention: $278,476
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $109,726
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $ 110,564
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Alabama received funding to build HAI infrastructure and conduct surveillance

Alaska

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $341,967
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $319,298
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $107,500
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Alaska received funding to build HAI infrastructure

Arizona

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $582,230
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $478,599
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $110,000
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $182,500
    • Activities: HAI Prevention Infrastructure and Implementation of Laboratory Tests for HAIs and Antimicrobial-Resistant Pathogens
  • From 2009-2012 Arizona received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Arkansas

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $988,084
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $491,478
    • Targeted Infection Prevention: $1,362,114
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $110,500
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Arkansas received funding to build HAI infrastructure

California

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $2,126,016
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Hemodialysis Bloodstream Infections (BSI); Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $831,292
    • Activities: HAI Prevention Infrastructure, Antimicrobial Resistance (AR) Prevention, Hemodialysis BSI Prevention, and Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $1,943,953
    • Targeted Infection Prevention: $2,246,870
  • 2014 ELC Funding Amount: $779,745
    • Activities: HAI Prevention Infrastructure, Antimicrobial Stewardship, Clostridium difficile (CDI) infection, Hemodialysis BSI, Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $663,425
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 California received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Colorado

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,236,089
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Data Validation; Hemodialysis Bloodstream Infections (BSI); Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $367,426
    • Activities: HAI Prevention Infrastructure, Data Validation, Hemodialysis BSI, and Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $469,436
    • Targeted Infection Prevention: $1,521,030
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $351,317
    • Activities: HAI Prevention Infrastructure, Data Validation, Hemodialysis BSI, and Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $175,850
    • Activities: HAI Prevention Infrastructure and Improving Health Department Capacity to Provide Infection Prevention and Control Assistance
  • From 2009-2012 Colorado received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Connecticut

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $573,719
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $180,832
    • Activities: HAI Prevention Infrastructure and Hemodialysis
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $1,045,768
    • Targeted Infection Prevention: $2,093,905
  • 2014 Affordable Care Act (ACA) funding amount:  $180,595
    • Activities: HAI Prevention Infrastructure and Hemodialysis BSI
  • 2013 Affordable Care Act (ACA) funding amount: $435,994
    • Activities: HAI Prevention Infrastructure and HAI Prevention across the spectrum of healthcare
  • From 2009-2012 Connecticut received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Delaware

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $383,592
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $609,077
    • Targeted Infection Prevention: $298,300
  • 2014 ELC Funding Amount: $102,405
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $89,911
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Delaware received funding to build HAI infrastructure

District of Columbia

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $380,532
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $324,749
    • Targeted Infection Prevention: $624,465
  • 2014 ELC Funding Amount: $108,500
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,295
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 District of Columbia received funding to build HAI infrastructure

Florida

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,069,419
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $503,284
    • Targeted Infection Prevention: $1,510,010
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount :  $154,230
    • Activities: HAI Prevention Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE)
  • 2013 Affordable Care Act (ACA) funding amount: $385,994
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Florida received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Georgia

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,017,058
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Data Validation; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $163,249
    • Activities: HAI Prevention Infrastructure and Antimicrobial Resistance (AR) Prevention Program
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $515,259
    • Targeted Infection Prevention: $1,753,039
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $218,256
    • Activities: HAI Prevention Infrastructure, Antimicrobial Stewardship, and Carbapenem-resistant Enterobacteriaceae (CRE)
  • 2013 Affordable Care Act (ACA) funding amount: $270,693
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Georgia received funding to build HAI infrastructure

Hawaii

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $398,267
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $232,959
  • 2014 ELC Funding Amount: $108,157
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $105,100
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Hawaii received funding to build HAI infrastructure and engage in prevention activities

Idaho

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $210,995
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $90,476
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $507,871
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $77,901
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $71,527
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Idaho received funding to build HAI infrastructure and conduct surveillance

Illinois

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,337,072
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount : $815,588
    • Activities: HAI Prevention Infrastructure and Antimicrobial Resistance (AR) Prevention Program
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $481,324
    • Targeted Infection Prevention: $2,206,110
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount : $813,506
    • Activities: HAI Prevention Infrastructure;  Antimicrobial Stewardship; Clostridium difficile infection(CDI);  and Carbapenem-resistant Enterobacteriaceae (CRE)
  • 2013 Affordable Care Act (ACA) funding amount: $490,848
    • Activities: HAI Prevention Infrastructure; Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare; and Improving Antimicrobial Use to Decrease Antimicrobial Resistant HAIs and Clostridium difficile infections
  • From 2009-2012 Illinois received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Indiana

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $398,902
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $93,354
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $319,931
    • Targeted Infection Prevention: $644,671
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $90,651
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $89,660
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Indiana received funding to build HAI infrastructure and engage in prevention activities

Iowa

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $446,964
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $411,800
    • Targeted Infection Prevention: $969,604
  • 2014 ELC Funding Amount: $109,500
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $106,454
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Iowa received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Kansas

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $481,569
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $406,866
  • 2014 ELC Funding Amount: $107,304
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $105,877
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Kansas received funding to build HAI infrastructure and conduct surveillance

Kentucky

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $977,917
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $583,506
    • Targeted Infection Prevention: $1,284,493
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount :  $109,500
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $253,877
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Kentucky received funding to build HAI infrastructure

Louisiana

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $389,453
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $104,793
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $633,355
    • Targeted Infection Prevention: $930,522
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $103,001
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $105,000
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Louisiana received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Maine

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $385,678
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $102,383
    • Targeted Infection Prevention: $506,182
  • 2014 Affordable Care Act (ACA) funding amount: $110,000
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Maine received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Maryland

  • One of 10 state health departments in the Emerging Infections Programs (EIP) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $2,752,575
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $690,405
    • Targeted Infection Prevention: $1,314,012
  • 2014 ELC Funding Amount: $109,500
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $281,500
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Maryland received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Massachusetts

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,258,916
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Data Validation; Hemodialysis Bloodstream Infections (BSI); and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $468,006
    • Activities: HAI Prevention Infrastructure, Antimicrobial Resistance (AR) Prevention Program, Data Validation, and Hemodialysis
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $658,747
    • Targeted Infection Prevention: $1,655,637
  • 2014 Affordable Care Act (ACA) funding amount: $396,961
    • Activity: HAI Prevention Infrastructure, Clostridium difficile infection (CDI), Data Validation, and Hemodialysis BSI
  • 2013 Affordable Care Act (ACA) funding amount: $704,151
    • Activities: HAI Prevention Infrastructure, Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare, and Initial Implementation of the CLABSI Validation Guidance to Ensure the Quality of HAI Data
  • From 2009-2012 Massachusetts received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Michigan

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,239,481
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $367,312
    • Activities: HAI Prevention Infrastructure and Antimicrobial Resistance (AR) Prevention Program
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $461,464
    • Targeted Infection Prevention: $972,582
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $367,812
    • Activities: HAI Prevention Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE)
  • 2013 Affordable Care Act (ACA) funding amount: $452,993.33
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Michigan received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Minnesota

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $3,933,431
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Injection Safety; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount : $493,343
    • Activities: HAI Prevention Infrastructure; Antimicrobial Resistance (AR) Prevention Program and Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $805,141
    • Targeted Infection Prevention: $3,346,627
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount : $491,343
    • Activities: HAI Prevention Infrastructure; Clostridium difficile infection (CDI);  Carbapenem-resistant Enterobacteriaceae (CRE); and Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $344,922
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Minnesota received funding to build HAI infrastructure and engage in prevention activities

Mississippi

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $215,162
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $104,179
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $413,957
    • Targeted Infection Prevention: $997,849
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $93,961
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $93,756
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Mississippi received funding to build HAI infrastructure and engage in prevention activities

Missouri

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $207,470
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $68,763
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $34,416
    • Targeted Infection Prevention: $472,006
  • 2014 ELC Funding Amount: $68,428
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $70,426
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Missouri received funding to build HAI infrastructure

Montana

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $842,215
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $463,162
    • Targeted Infection Prevention: $256,862
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $109,500
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $99,467
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Montana received funding to build HAI infrastructure

Nebraska

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,076,000
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $1,839,598
    • Targeted Infection Prevention: $1,061,839
  • 2014 ELC Funding Amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,334
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Nebraska received funding to build HAI infrastructure

Nevada

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $503,741
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $786,148
    • Targeted Infection Prevention: $681,066
  • 2014 ELC Funding Amount: $108,432
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $106,683
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Nevada received funding to build HAI infrastructure

New Hampshire

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $556,635
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $138,601
    • Targeted Infection Prevention: $451,031
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $107,679
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $111,568
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 New Hampshire received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

New Jersey

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $591,853
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $203,999
    • Activities: HAI Prevention Infrastructure, Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $586,925
    • Targeted Infection Prevention: $2,155,167
  • 2014 ELC Funding Amount: $206,500
    • Activity: HAI Prevention Infrastructure and Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $287,500
    • Activities: HAI Prevention Infrastructure and Improving Health Department Capacity to Provide Infection Prevention and Control Assistance
  • From 2009-2012 New Jersey received funding to build HAI infrastructure and conduct surveillance

New Mexico

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $999,953
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Data Vaidation; Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $176,971
    • Activities: HAI Prevention Infrastructure and Data Validation
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $452,007
    • Targeted Infection Prevention: $273,277
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $174,971
    • Activities: HAI Prevention Infrastructure and Data Validation
  • 2013 Affordable Care Act (ACA) funding amount: $312,461
    • Activities: HAI Prevention Infrastructure; Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare; and Initial Implementation of the CLABSI Validation Guidance to Ensure the Quality of HAI Data
  • From 2009-2012 New Mexico received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

New York

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $3,202,438
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Injection Safety; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $696,618
    • Activities: HAI Prevention Infrastructure, Antimicrobial Resistance (AR) Prevention, and Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $585,074
    • Targeted Infection Prevention: $1,970,553
  • 2014 ELC Funding Amount: $690,306
    • Activities: HAI Prevention Infrastructure, Clostridium difficile infection (CDI), Carbapenem-resistant Enterobacteriaceae (CRE), and Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $871,090
    • Activities: HAI Prevention Infrastructure, Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare, and Improving Health Department Capacity to Provide Infection Prevention and Control Assistance
  • From 2009-2012 New York received funding to build HAI infrastructure and engage in prevention activities

North Carolina

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $711,769
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $144,500
    • Activities: HAI Prevention Infrastructure and Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $444,211
    • Targeted Infection Prevention: $1,610,779
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $143,000
    • Activities: HAI Prevention Infrastructure and Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $143,469
    • Activities: HAI Prevention Infrastructure and Improving Health Department Capacity to Provide Infection Prevention and Control Assistance
  • From 2009-2012 North Carolina received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

North Dakota

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $383,464
    • Activities: HAI Detection and Response Infrastructure; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $101,114
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $160,731
    • Targeted Infection Prevention: $161,213
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $108,217
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $87,209
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 North Dakota received funding to build HAI infrastructure

Ohio

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $356,801
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $1,497,114
    • Targeted Infection Prevention: $280,003
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $107,500
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $90,968
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Ohio received funding to build HAI infrastructure and conduct surveillance

Oklahoma

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $416,039
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $107,500
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Oklahoma received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Oregon

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,301,537
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $509,953
    • Activities: HAI Prevention Infrastructure; Antimicrobial Resistance (AR) Prevention Program, and Injection Safety
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $545,633
    • Targeted Infection Prevention: $2,137,548
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $502,024
    • Activities: HAI Prevention Infrastructure; Clostridium difficile infection (CDI) and Carbapenem-resistant Enterobacteriaceae (CRE)
  • 2013 Affordable Care Act (ACA) funding amount: $929,141
    • Activities: HAI Prevention Infrastructure; Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare; Regional Multidrug-Resistant Organism (MDROs) Prevention and Detection; and Initial Implementation of the CLABSI Validation Guidance to Ensure the Quality of HAI Data
  • From 2009-2012 Oregon received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Pennsylvania

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,184,275
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $811,042
    • Targeted Infection Prevention: $1,181,209
  • 2014 ELC Funding Amount: $107,744
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $147,926
    • Activities: Improving Antimicrobial Use to Decrease Antimicrobial Resistant HAIs and Clostridium difficile infections and Identifying Cost-effective and Evidence-based HAI Interventions Sub-activities
  • From 2009-2012 Pennsylvania received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Puerto Rico

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $393,710
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $93,417
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $274,396
    • Targeted Infection Prevention: $99,948
  • 2014 ELC Funding Amount: $86,940
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $90,845
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Puerto Rico received funding to build HAI infrastructure

Rhode Island

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $780,233
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $99,987
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $176,628
    • Targeted Infection Prevention: $264,314
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $101,379
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $88,713.67
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Rhode Island received funding to build HAI infrastructure

South Carolina

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $934,344
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $492,866
    • Targeted Infection Prevention: $1,575,547
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $108,609
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 South Carolina received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

South Dakota

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $585,538
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $328,806
    • Targeted Infection Prevention: $192,034
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $110,000
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $90,957
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 South Dakota received funding to build HAI infrastructure

Tennessee

  • One of 10 state health departments in the Emerging Infections Programs (EIP)(https://www.cdc.gov/hai/eip/index.html) network
  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $4,487,315
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Data Validation; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount:  $748,207
    • Activities: HAI Prevention Infrastructure, Antimicrobial Resistance (AR) Prevention Program, Data Validation, and Hemodialysis BSI
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $484,657
    • Targeted Infection Prevention: $1,759,091
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $737,694
    • Activities: HAI Prevention Infrastructure, Clostridium difficile infection (CDI), Carbapenem-resistant Enterobacteriaceae (CRE), Data Validation, and Hemodialysis BSI
  • 2013 Affordable Care Act (ACA) funding amount: $104,142
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Tennessee received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Texas

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $2,108,579
    • Activities: HAI Detection and Response Infrastructure; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $92,900
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $1,026,231
    • Targeted Infection Prevention: $587,209
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $85,075
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2011 Texas received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Utah

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $821,031
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $586,669
    • Targeted Infection Prevention: $1,361,468
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $151,376
    • Activities: HAI Prevention Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE)
  • 2013 Affordable Care Act (ACA) funding amount: $413,343
    • Activities: HAI Prevention Infrastructure and Regional Multidrug-Resistant Organism (MDROs) Prevention and Detection
  • From 2009-2012 Utah received funding to build HAI infrastructure

Vermont

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $268,083
    • Activities: HAI Detection and Response Infrastructure; Injection Safety; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $106,804
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $93,348
    • Targeted Infection Prevention: $398,468
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $108,490
    • Activities: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $308,730
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Vermont received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Virginia

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $1,218,864
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $546,742
  • 2014 ELC Funding Amount: $109,270
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $111,028
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Virginia received funding to build HAI infrastructure, conduct surveillance, and engage in prevention activities

Washington

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $3,364,804
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; Coordinated Prevention; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount : $272,493
    • Activities: HAI Prevention Infrastructure and Antimicrobial Resistance (AR) Prevention Program
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $918,833
    • Targeted Infection Prevention: $1,081,167
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $240,993
    • Activities: HAI Prevention Infrastructure and Antimicrobial Stewardship
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 Washington received funding to build HAI infrastructure and conduct surveillance

West Virginia

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $573,708
    • Activities: Educational Efforts to Promote Appropriate Antibiotic Use; HAI Detection and Response Infrastructure; and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $109,500
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $563,189
    • Targeted Infection Prevention: $812,430
  • 2014 ELC Funding Amount: $108,052
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $107,500
    • Activity: HAI Prevention Infrastructure
  • From 2009-2012 West Virginia received funding to build HAI infrastructure

Wisconsin

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $2,632,416
    • Activities: HAI Detection and Response Infrastructure; Coordinated Prevention; Data Validation; Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity; and Antimicrobial Resistance Regional Laboratory Network (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $328,844
    • Activities: HAI Prevention Infrastructure and Antimicrobial Resistance (AR) Prevention Program
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $567,235
    • Targeted Infection Prevention: $446,235
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $346,717
    • Activities: HAI Prevention Infrastructure; Carbapenem-resistant Enterobacteriaceae (CRE); and Injection Safety
  • 2013 Affordable Care Act (ACA) funding amount: $133,916
    • Activities: HAI Prevention Infrastructure and Prevention of Healthcare-associated Infections Across the Spectrum of Healthcare
  • From 2009-2012 Wisconsin received funding to build HAI infrastructure; conduct surveillance; and engage in prevention activities

Wyoming

  • 2016 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $187,918
    • Activities: HAI Detection and Response Infrastructure and Carbapenem-resistant Enterobacteriaceae (CRE) Laboratory Capacity (see ELC HAI-funded Activities for more information)
  • 2015 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $57,106
    • Activities: HAI Prevention Infrastructure
  • 2015 ELC domestic Ebola supplement: Infection Control Assessment and Response (ICAR) Program
    • Infection Control Assessment Program: $206,080
  • 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding amount: $58,928
    • Activity: HAI Prevention Infrastructure
  • 2013 Affordable Care Act (ACA) funding amount: $49,768
    • Activity: HAI Prevention Infrastructure
  • From 2011-2012 Wyoming received funding to build HAI infrastructure